One of Europe’s largest and most experienced service providers
GBA Group Pharma is a member of the GBA Group and a unique service provider for the international pharmaceutical and biotech industry, with six locations across Austria and Germany. The well-known companies Pharmacelsus, GBA Pharma Labs, LKF Central Laboratory and ABF Pharmaceutical Services operate under the roof of GBA Group Pharma.
From early lead optimization and early preclinical stage to global clinical studies, we support clients throughout the entire lifecycle with our worldwide acting central laboratory, GMP depots, EU GMP manufacturing site for labeling and packaging and QP services, as well as late drug development and analytical services including import testing and QP batch release.
GBA Group Pharma is one of Europe’s largest and most experienced service providers for the pharmaceutical and biotech sector and has a total of 400 employees in Austria, Germany and the UK.
Brexit Safe Haven
We at GBA Group Pharma are one of a few vendors in the area of QP release, import into Europe as well as batch release testing that can grant CTSM (clinical trial supply management) and commercial supply after Brexit without any implications on our clients.
New GMP facilities for CTSM and commercials in Vienna place the company in a unique position as EMA clearly states that GMP depots, QP release activities and GMP testing must be located in the EU. The growth in size and service offerings will make GBA Group Pharma one of only a few companies able to offer a Brexit Proof Solution to the pharmaceutical industry.
Zitat Elisabeth Lackner, CEO ABF & GBA Group Pharma:
‘EMA specifies clear regulations for medicines manufactured in the EU. When UK leaves the EU, GBA Group Pharma will be one of the few service provider in the EU who can meet this criteria’